AccurEdit Therapeutics
Going beyond disease management
Jiangsu, United States · Founded 2021 · $75.0M raised
- Headquarters
- Jiangsu
- Founded
- 2021
- Business Model
- B2B
- Website
- accuredit.com
- Total Funding
- $75.0M
- Last Round
- $75.0M SeedAug 2023
- Rounds
- 2
About
AccurEdit Therapeutics is committed to developing cures for severe and life-threatening diseases through in vivo gene editing. The company has established an industry-leading end-to-end technology platform focused on RNA synthesis, editing, and delivery technologies. In October 2023, AccurEdit became the first company in China to demonstrate safe and effective systemic CRISPR gene editing in humans. Its lead program ART001 is an LNP-delivered in vivo gene editing therapy and received FDA RMAT designation. AccurEdit follows a patient-oriented philosophy pursuing single-dose curative therapy via a highly efficient technology platform.
Summary
AccurEdit Therapeutics is a Biotechnology company based in Jiangsu, United States, founded in 2021. It has raised $75.0M in total across 2 rounds, most recently a $75.0M Seed round in Aug 2023. Investors include Legend Capital and Cormorant Asset Management.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2023
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Biotechnology company focused on developing and commercializing innovative, empowered monoclonal ...
Biotechnology company focused on the development of antibody-drug conjugates for the treatment of...
Clinical-stage ophthalmic gene therapy company developing AAV-based treatments for rare and preva...
Leading innovative radiopharmaceutical company in China developing next-generation radiopharmaceu...
Clinical-stage biotechnology company pioneering GPCR drug discovery through its proprietary Nativ...
Clinical-stage biopharmaceutical company developing small-molecule therapies for serious diseases...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/accuredit-therapeutics"><img src="https://indexed.vc/api/badge/company/accuredit-therapeutics" alt="AccurEdit Therapeutics on Indexed.vc" width="260" height="76" /></a>